JND-32066

N/A

Report date: 2023/04/02 18:55:17
NME

Base Information

Drug NameJND-32066
Drug Alias NameJND-32066
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptors antagonistsNerve growth factor receptor Trk-A inhibitors
TargetsFibroblast growth factor receptorsNerve growth factor receptor Trk-A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesLixin PharmaceuticalsJinan University
China Registration ClassN/A

Develop Information

Active CompaniesLixin PharmaceuticalsJinan University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A